PCN108 Economic Evaluation of Sunitinib Malate for the First-Line Treatment of Metastaric Renal Cell Carcinoma in the Chinese Health Care Setting
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1209
https://www.valueinhealthjournal.com/article/S1098-3015(11)02771-9/fulltext
Title :
PCN108 Economic Evaluation of Sunitinib Malate for the First-Line Treatment of Metastaric Renal Cell Carcinoma in the Chinese Health Care Setting
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02771-9&doi=10.1016/j.jval.2011.08.1209
First page :
A454
Section Title :
Cancer
Open access? :
No
Section Order :
1169